Cargando…
Gulonolactone Addition to Human Hepatocellular Carcinoma Cells with Gene Transfer of Gulonolactone Oxidase Restores Ascorbate Biosynthesis and Reduces Hypoxia Inducible Factor 1
Humans are unable to synthesise ascorbate (Vitamin C) due to the lack of a functional gulonolactone oxidase (Gulo), the enzyme that catalyses the final step in the biosynthesis pathway. Ascorbate is a vital micronutrient required for many biological functions, including as a cofactor for metalloenzy...
Autores principales: | Flett, Teresa, Campbell, Elizabeth J., Phillips, Elisabeth, Vissers, Margreet C. M., Dachs, Gabi U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423483/ https://www.ncbi.nlm.nih.gov/pubmed/28548062 http://dx.doi.org/10.3390/biomedicines2010098 |
Ejemplares similares
-
Growth and Antioxidant-Related Effects of the Reestablished Ascorbic Acid Pathway in Zebrafish (Danio rerio) by Genomic Integration of L-Gulonolactone Oxidase From Cloudy Catshark (Scyliorhinus torazame)
por: Shanaka, K. A. S. N., et al.
Publicado: (2021) -
Multiple independent L-gulonolactone oxidase (GULO) gene losses and vitamin C synthesis reacquisition events in non-Deuterostomian animal species
por: Henriques, Sílvia F., et al.
Publicado: (2019) -
The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
por: Wohlrab, Christina, et al.
Publicado: (2018) -
Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo(−/−) mice
por: Campbell, Elizabeth J, et al.
Publicado: (2016) -
Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(−/−) mice
por: Campbell, Elizabeth J, et al.
Publicado: (2015)